Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in adolescents with chronic hepatitis C virus: part 1 of the DORA study | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in adolescents with chronic hepatitis C virus: part 1 of the DORA study

Jonas MM, Squires RH, Rhee S, et al. Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in adolescents with chronic hepatitis C virus: part 1 of the DORA study. Hepatology. 2019;:[Epub ahead of print].

Publication Type:

Journal Article

Authors:

Jonas, MM; Squires, RH; Rhee, S; et, al

Source:

Hepatology, p.[Epub ahead of print] (2019)

Cited On:

HCV in Children

Export Citation:

RIS Format

Top